SynthesisJAMA network open2024

Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis.

Yixin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.